| Description |
This event is THE essential one-stop shop providing pharma and life sciences lawyers with the crucial tools and guidance to stay one step ahead of the key changes in IP, competition law and regulations impacting the pharmaceutical industry.
In-house industry leaders and outside experts will explore the critical topics from the standpoint of both innovators and generic producers. Stay inside the lines with the latest updates on regulations and competition law, learn how to profitably and legally market your products, and understand what issues are shaping the parallel trade debate now. Learn about how to enhance your licensing strategies and efficiently manage and extend the patent lifecycle. Hear industry updates on the GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim cases, not to mention the latest news on the EU pharmaceutical inquiry .
This is the only event designed to give a comprehensive and sophisticated update existing EU and emerging markets. Our expert speakers will help you to take advantage of the opportunities available and maximise the protection and profit afforded under Pharma law. Highlights from this November's programme include:
EC Task Force presentation on the pharmaceutical inquiry
Navigating complex parallel trade issues: an up-to-date examination
An advanced look at managing clinical trials risks in the EU, Russia, Asia and Latin America
Pharma law regimes, opportunities and risks in emerging markets: R&D in India, Medical Devices in Turkey, and a look into patents in the newest EU member states
Improved and in-depth presentations on Biosimilars
Minimising the risk of anti-corruption violations under the FCPA
Life cycle management and licensing strategies
Combating counterfeits with the latest technological and legal strategies
And of course, all the essential legal updates from the EU!
Upcoming legal and regulatory changes may drastically alter the way you operate in the pharmaceutical industry. Ensure that your company or firm is up to date and understands all the latest developments and strategies being used by the pharmaceutical industry to practise and profit in the EU. Additionally, don't miss out on the chance to speak face to face with our distinguished faculty which includes:
Sune Chabert Larsen, Case Handler for the EC Task Force Pharmaceutical Inquiry
Aaron Graham, Vice President and Chief Security Officer, Purdue Pharma
Alexandre Mencik, Senior Legal Counsel, Amgen
Ray Cresswell, VP Legal, GlaxoSmithKline
Christof Bull, Director and Senior Patent Counsel for UCB Group - Brussels
Dr. Francesco Patalan, Managing Director, SkyePharma AG
Suzanne Smith, General Counsel and Company Secretary, Phoqus Pharmaceuticals
Donise Winter, Assistant General Counse, Pfizer
Tony Rollins, Managing Counsel for Europe, Merck, Sharpe & Dohme
Umit Dereli, Director of Strategic Affairs, Johnson & Johnson Turkey
Carla Schoonderbeek, Partner and Head of Life Sciences Group, NautaDutilh
Bart van der Lelie, Director of Corporate Affairs, Schering-Plough
Don't miss out – register today for this comprehensive and informative event!
|
|
